Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Tonix Pharmaceuticals Holding Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

14 May 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Tonix Pharmaceuticals Holding Corp (TNXP-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

19 May 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for TNXP

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

15 May 2016 ValuEngine, Inc. 11 $25.00

TONIX PHARMACEUTICALS HOLDING CP (TNXP=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

14 May 2016 Pechala's Reports 2 $25.00

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review Summary Tonix Pharmaceuticals Holding Corp. (TONIX) is...

13 May 2016 GlobalData 50 $300.00

Tonix Pharmaceutical Hldg

30 Apr 2016 S&P Capital IQ Factual Report 13 $150.00

TONIX PHARMACEUTICALS - FIBROMYALGIA AND PTSD DATA COMING UP

Tonix is developing TNX-102 SL, a sublingual formulation of cyclobenzaprine for two large indications, fibromyalgia and post-...

01 Apr 2016 Edison Investment Research 12 $10.00

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review Summary Tonix Pharmaceuticals Holding Corp. (TONIX) is...

17 Mar 2016 GlobalData 53 $300.00

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review

Tonix Pharmaceuticals Holding Corp. (TNXP) - Financial Analysis Review Summary Tonix Pharmaceuticals Holding Corp. (TONIX) is...

14 Dec 2015 GlobalData 51 $300.00

TONIX PHARMACEUTICALS - ADDITIONAL DATA SUPPORT MECHANISM OF ACTION

Data from the Phase IIb BESTFIT trial reported at the American College of Rheumatology (ACR) conference support the idea that...

24 Nov 2015 Edison Investment Research 8 $10.00